Pre-made Fibatuzumab benchmark antibody ( Whole mAb, anti-EPHA3 therapeutic antibody, Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 Antibody) for drug discovery and mechanism of action (MOA) researchCat No.: GMP-Bios-ab-211
Pre-Made Fibatuzumab biosimilar, Whole mAb, Anti-EPHA3 Antibody: Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Fibatuzumab is a humanised monoclonal antibody directed against the ephrin receptor A3 (EPHA3) , which is a receptor tyrosine kinase implicated in mediating nervous system development .
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Pre-Made Fibatuzumab biosimilar, Whole mAb, Anti-EPHA3 Antibody: Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic antibody|
|Highest_Clin_Trial (Jan '20)||Phase-II|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Ludwig Institute for Cancer Research;Humanigen;Olivia Newton-John Cancer Research Institute|
|Conditions Active||Acute myeloid leukaemia;Myelodysplastic syndromes;Myelofibrosis;Glioblastoma|
|Development Tech||POTELLIGENT Technology;Humaneering Technology|